Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Tables)

v3.24.3
STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2024
STOCKHOLDERS' EQUITY  
Schedule of restricted stock unit activity

Weighted Average

    

Amount

    

Grant Date Fair Value

    

Outstanding at December 31, 2023

532,399

$

14.82

Granted

1,148,201

 

7.07

Forfeited

(67,887)

 

14.64

Vested

(221,337)

14.90

Outstanding September 30, 2024

1,391,376

$

8.43

Weighted Average

    

Amount

    

Grant Date Fair Value

    

Outstanding at December 31, 2022

1,374,383

$

10.72

Granted

359,036

 

15.01

Forfeited

(33,526)

14.86

Vested

(121,737)

14.28

Outstanding September 30, 2023

1,578,156

$

11.34

Schedule of options granted

Grant Date

Grant Date

June 7, 2024

July 1, 2024

Risk-free interest rate

4.42%

4.44%

Expected volatility of common stock

50.04%

50.03%

Dividend yield

-

-

Expected option term in years

6.0

6.0

Grant-date fair value (per share)

$ 3.73

$ 3.46

Schedule of stock options activity

Amount

Weighted Average Exercise Price per Share

Weighted Average Remaining Contractual Life (Years)

Aggregate Intrinsic Value (1)

Outstanding at December 31, 2023

-

$

-

-

-

Granted

646,301

7.02

9.69

-

Forfeited

-

-

-

-

Vested

-

-

-

-

Outstanding at September 30, 2024

646,301

$

7.02

9.69

Exercisable

-

$

-

-

-

(1) Total shares valued at the market price of the underlying stock as of September 30, 2024 less the exercise price.